DAVID DOWNEY: Open Payments
NPI 1225140536 · CICERO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 43 payments from 16 companies in 2025. Trend: 2023 $1,125 · 2024 $804 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $211 |
| Merck Sharp & Dohme LLC | 5 | $116 |
| Actelion Pharmaceuticals US, Inc. | 4 | $111 |
| Edwards Lifesciences Corporation | 1 | $101 |
| Amgen Inc. | 6 | $82 |
| BridgeBio Pharma, Inc. | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Novo Nordisk Inc | 2 | $35 |
| PFIZER INC. | 2 | $32 |
Products named: LEQVIO, VERQUVO, REPATHA, UPTRAVI, OPSUMIT, Attruby, Kerendia, Wegovy.
Industry payments across NY — which companies pay providers there.
